Subcutaneous insulin detemir compared with NPH insulin increases brain potential responses with similar systemic metabolic effects in people with Type 1 diabetes

被引：0
|
作者：
Herring, R. [1 ]
Shojaee-Moradie, F. [2 ]
Umpleby, M. [2 ]
Jackson, N. [2 ]
Jones, R. [2 ]
Derk-Jan, D. [3 ]
Knight, R. [3 ]
Russell-Jones, D. [1 ]
机构：
[1] Royal Surrey Cty Hosp, Ctr Endocrinol Diabet & Res, Guildford, Surrey, England
[2] Univ Surrey, Guildford GU2 5XH, Surrey, England
[3] Univ Surrey, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England
来源：
DIABETIC MEDICINE | 2014年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
    Robertson, K. J.
    Schoenle, E.
    Gucev, Z.
    Mordhorst, L.
    Gall, M. -A.
    Ludvigsson, J.
    [J]. DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
  • [2] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
    Kolendorf, K
    Prasek, M
    Santeusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETOLOGIA, 2004, 47 : A329 - A329
  • [3] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with type 1 diabetes
    Kolendorf, K
    Pavlic-Renar, I
    San-Teusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETES, 2004, 53 : A130 - A131
  • [4] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - A randomized clinical trial
    Home, P
    Bartley, P
    Russell-Jones, D
    Hanaire-Broutin, H
    Heeg, JE
    Abrams, P
    Landin-Olsson, M
    Hylleberg, B
    Lang, H
    Draeger, E
    [J]. DIABETES CARE, 2004, 27 (05) : 1081 - 1087
  • [5] The Effects of Subcutaneous Insulin NPH and Detemir on Glucose Flux and Lipolysis Following a Period of Insulin Withdrawal in Patients With Type 1 Diabetes
    Herring, Roselle
    Shojaee-Moradie, Fariba
    Jackson, Nicola
    Jones, Richard
    Umpleby, Margot
    Russell-Jones, David L.
    [J]. DIABETES, 2013, 62 : A492 - A492
  • [6] Once daily dosing with insulin detemir offers advantages compared to NPH insulin in subjects with type 1 diabetes
    Russel-Jones, D
    Bolinder, J
    Simpson, R
    Stades, A
    Stender, A
    Hylleberg, B
    Draeger, E
    [J]. DIABETES, 2003, 52 : A132 - A132
  • [7] Insulin Detemir Increases Cerebral Glucose Metabolism Compared to NPH Insulin in Human Type 1 Diabetes: Possible Explanation for Differences in Weight Gain?
    Van Golen, Larissa W.
    Huisman, Marc C.
    Ijzerman, Richard G.
    Hoetjes, Nikie J.
    Schwarte, Lothar A.
    Schober, Patrick
    Hoogma, Roel P.
    Drent, Madeleine L.
    Lammertsma, Adriaan A.
    Diamant, Michaela
    [J]. DIABETES, 2011, 60 : A421 - A421
  • [8] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - Response to Home et al.
    Kiess, W
    Raile, K
    Galler, A
    Kapellen, T
    [J]. DIABETES CARE, 2004, 27 (10) : 2567 - 2568
  • [9] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
    Heise, T
    Nosek, L
    Ronn, BB
    Endahl, L
    Heinemann, L
    Kapitza, C
    Draeger, E
    [J]. DIABETES, 2004, 53 (06) : 1614 - 1620
  • [10] A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes
    Home, PD
    Rosskamp, R
    Forjanic-Klapproth, J
    Dressler, A
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) : 545 - 553
12345